Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Transition Therapeutics Inc (TTH.TO)

TOP PICK
A speculative pick. They are going after diabetes, one of the biggest health problems in the world. So far, test have only been done with mice but success has been good. Risky, so don't invest too much. High risk/high reward.
WEAK BUY
Have some early-stage products which makes it a cheap company. A higher risk name. Good management.
Showing 16 to 17 of 17 entries